307
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Effectiveness of biological therapy in reducing psoriasis-related cardiovascular risk

, , , , , , , , , , & show all
Pages 217-219 | Received 13 Dec 2023, Accepted 26 Mar 2024, Published online: 01 Apr 2024
 

Declaration of interest

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

Reviewer disclosures

A reviewer on this manuscript has disclosed that they have been an investigator on several clinical trials for biologics in this indication in the U.S.A. and are a member of the advisory boards for Abbvie, Eli Lilly, Amgen, Janssen, Pfizer, UCB and BMS. Peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.

Author contributions

S Boskovic and S Borriello have given substantial contributions to the conception or the design of the manuscript. All authors have participated in drafting the manuscript. All authors read and approved the final version of the manuscript.

Additional information

Funding

This manuscript was funded through a donation by AbbVie S.p.a.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.